News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lyssikatos Joseph P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Lyssikatos Joseph P (Chief Scientific Officer) has filed a Form 4 on Enliven Therapeutics, Inc.|
Txns:
| Sold 12,000 shares
@ $13.6248, valued at
$163.5k
Exercised 12,000 options to buy
@ $1.12, valued at
$13.4k
|
|
| 09/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/27/2023 |
4
| Lyssikatos Joseph P (Chief Scientific Officer) has filed a Form 4 on Enliven Therapeutics, Inc.|
Txns:
| Granted 1,117,035 shares
@ $0
Granted 344,550 options to buy
@ $1.12, valued at
$385.9k
Granted 88,531 options to buy
@ $2.48, valued at
$219.6k
|
|
| 02/27/2023 |
3
| Lyssikatos Joseph P (Chief Scientific Officer) has filed a Form 3 on Enliven Therapeutics, Inc. |
|
|